HomeAVXL • NASDAQ
add
Anavex Life Sciences Corp
Previous close
$11.23
Day range
$10.04 - $11.07
Year range
$3.25 - $14.44
Market cap
894.80M USD
Avg Volume
2.23M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
PLUR
0.24%
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 13.64M | 13.80% |
Net income | -11.62M | -14.53% |
Net profit margin | — | — |
Earnings per share | -0.14 | -16.67% |
EBITDA | — | — |
Effective tax rate | 1.06% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 132.19M | -12.47% |
Total assets | 135.57M | -12.19% |
Total liabilities | 15.30M | 22.10% |
Total equity | 120.26M | — |
Shares outstanding | 84.82M | — |
Price to book | 7.91 | — |
Return on assets | -24.60% | — |
Return on capital | -27.27% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -11.62M | -14.53% |
Cash from operations | -6.66M | -13.83% |
Cash from investing | — | — |
Cash from financing | 89.00K | -95.67% |
Net change in cash | -6.57M | -73.19% |
Free cash flow | -3.56M | -11.53% |
About
Founded
2004
Headquarters
Website
Employees
42